Clinical Trial Update: A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC

View source ↗

Summary

A real-world study evaluating the efficacy and safety of Adebrelimab in patients with advanced Small Cell Lung Cancer. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Adebrelimab (adebrelimab)

Snippet

Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Conditions: Small Cell Lung Cancer (SCLC) | Status: RECRUITING